PolyPeptide Group AG PolyPeptide Group AG

PolyPeptide Group AG

PPGN

Rank in Stocks #6687
PolyPeptide Group AG operates globally as a contract development and... PolyPeptide Group AG operates globally as a contract development and manufacturing organization (CDMO), specializing in the production of Good Manufacturing Practice (GMP)-grade peptides. These peptides, available in both proprietary and generic forms, are vital for pharmaceutical and biotechnology companies, serving as key ingredients in approved medicines, compounds undergoing clinical development, and generic drug formulations. The company also produces custom research-grade peptides and actively develops neoantigen peptides to support personalized cancer therapies. Its manufacturing expertise extends to peptides used in commercially approved therapeutics, peptide-based generics for human and veterinary applications, and cosmetic peptides. Additionally, PolyPeptide Group AG provides regulatory affairs support services. Founded in 1952 and headquartered in Zug, Switzerland, the company is a subsidiary of Draupnir Holding B.V.
Share Price
$49.22
Last synced: 2026-11-09
Market Cap
$1.63B
Change (1 day)
0.71%
Change (1 year)
62.59%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Category

Healthcare
Dividend history for PolyPeptide Group AG (PPGN)
PolyPeptide Group AG (stock symbol: PPGN) made a total of 1 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.31
Dividend yield (TTM) : 0.00%
Dividend payments for PolyPeptide Group AG (PPGN) from 2022 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
2026 (TTM) $0.31 0.00%
2022 $0.31 0.00%
List of all dividend payments
Year Dividend Change
2026 (TTM) $0.31 0.00%
2022 $0.31 0.00%
Dividend payments for similar companies or competitors